These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11653562)

  • 1. Position statement of the AFCR on FDA proposal to assign scientific review of new drugs for human use to local institutional review boards.
    American Federation for Clinical Research
    Clin Res; 1982 Feb; 30(1):27-8. PubMed ID: 11653562
    [No Abstract]   [Full Text] [Related]  

  • 2. Position statement of the AFCR on the issue of regulation of institutional review boards by the FDA.
    Clin Res; 1979 Apr; 27(2):109-11. PubMed ID: 10241073
    [No Abstract]   [Full Text] [Related]  

  • 3. Can (or should) the IRB assume the FDA's functions at early stages of the IND process?
    Levine RJ
    IRB; 1981 Dec; 3(10):4-5. PubMed ID: 11649414
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased review responsibilities for Australian institutional ethics committees.
    Darvall L
    IRB; 1995; 17(1):9. PubMed ID: 11653062
    [No Abstract]   [Full Text] [Related]  

  • 5. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of institutional review boards on clinical research.
    Levine RJ
    Perspect Biol Med; 1980 Pt 2): S99-S114, Winter; 23(2):. PubMed ID: 11663073
    [No Abstract]   [Full Text] [Related]  

  • 7. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 8. Institutional review boards now given explicit responsibility in new federal rule.
    Maloney DM
    Hum Res Rep; 1995 Feb; 10(2):1-2. PubMed ID: 11654158
    [No Abstract]   [Full Text] [Related]  

  • 9. Testing drugs in pediatric populations: the FDA mandate.
    Tauer CA
    Account Res; 1999; 7(1):37-58. PubMed ID: 11657562
    [No Abstract]   [Full Text] [Related]  

  • 10. Federal investigation concludes that institutional review boards are in trouble.
    Maloney DM
    Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
    [No Abstract]   [Full Text] [Related]  

  • 11. OPRR and FDA propose revised expedited review categories.
    McGough H
    IRB; 1998; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract]   [Full Text] [Related]  

  • 12. The noninstitutional review board: a case history.
    Herman SS
    IRB; 1984; 6(1):1-3, 12. PubMed ID: 11649540
    [No Abstract]   [Full Text] [Related]  

  • 13. A look at the bioresearch monitoring program: the agency perspective.
    Brisson EL
    Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical and psychological experimentation on California prisoners.
    Herch F; Flower R
    Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107
    [No Abstract]   [Full Text] [Related]  

  • 16. New initiative to accredit all institutional review boards.
    Maloney DM
    Hum Res Rep; 1999 Jul; 14(7):1-2. PubMed ID: 11658058
    [No Abstract]   [Full Text] [Related]  

  • 17. National commission proposes numerous new regulations of institutional review boards.
    Maloney DM
    Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
    [No Abstract]   [Full Text] [Related]  

  • 18. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of FDA, IRBs and regulations.
    Petricciani JC
    IRB; 1981 Dec; 3(10):1-3, 11. PubMed ID: 11649413
    [No Abstract]   [Full Text] [Related]  

  • 20. Annual review: observed deficiencies and suggested corrections.
    Adams MS; Conrad DA
    IRB; 1996; 18(6):1-4. PubMed ID: 11654743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.